Close Menu

The Scan

All in One Spot

Nature News reports that a new initiative aims to make the abstracts of scientific papers accessible at a central site.

In Genome Biology this week: graph mapping-based approach to find indels in ancient DNA, tool to analyze chromatin interaction data, and more.

Again?

A genomic analysis indicates a Nevada man has been infected with SARS-CoV-2 twice, CNBC reports.

A Different Pause

Stat News reports Johnson & Johnson has paused its SARS-CoV-2 vaccine trial due to an unexplained illness affecting a study participant.

The Associated Press reports the trial of a Greek man accused of the rape and murder of a US researcher has begun.

In PNAS this week: characterization of diarrhea-causing swine coronavirus, metabolic differences in models with TP53 variant, and more.

China has joined the World Health Organization-led SARS-CoV-2 vaccine effort, NPR reports.

Nevada's About Face

The New York Times reports Nevada has reversed a statewide order directing nursing homes to halt their use of two rapid coronavirus tests.

Confidence Shaken

The Washington Post writes that the coronavirus pandemic has shaken public confidence in US government scientists.

In PLOS this week: immune-related gene pairs linked to malignant melanoma outcomes, plasticity among paramyxoviruses, and more.

Moderna has announced it will not enforce its COVID-19 vaccine-related patents during the pandemic, the Wall Street Journal reports.

"Colossal Failure"

A former Centers for Disease Control and Prevention director calls on the current director, Robert Redfield, to address the agency's pandemic response shortcomings, USA Today reports.

Nature News reports that Australia's new budget includes AUS$1 billion in research funding to universities

In Science this week: analysis of mole genome sheds light on development of ovotestes.

In an editorial, the New England Journal of Medicine urges voting the current US leadership out, saying it is "dangerously incompetent."

Joan Marks Dies

Joan Marks, who shaped the field of genetic counseling, has died at 91, the New York Times reports.

In Nature this week: molecular profiling platform identifies treatments for pediatric cancer cases, metaFlye algorithm addresses challenges of long-read metagenomic assembly, and more.

CRISPR Chemistry Win

Emmanuelle Charpentier and Jennifer Doudna have won this year's Nobel Prize in Chemistry for their work developing the CRISPR gene editing tool, according to Reuters.

The Washington Post reports that the White House has approved new, stricter guidelines for seeking emergency authorization for a coronavirus vaccine.

Rick Bright, the former BARDA head, has left his new post at NIH, saying he's been "sidelined" there, NPR reports.

In Cell this week: analysis of multisystem inflammatory syndrome in children with SARS-CoV-2, fecal transplants boost gut microbiome development in infants born by C-section, and more.

According to the New York Times, the White House is preventing the release of stricter guidelines for the emergency authorization of a coronavirus vaccine.

Japan's prime minister has rejected six candidates for membership on a science council, sparking criticism, according to the Japan Times.

Rather Open Wide

The Los Angeles Times reports on the development of oral swabbing and saliva collection for COVID-19 testing.

In PNAS this week: rearrangements found in acute myeloid leukemia, DNA double-strand break repair patterns in model of hepatocellular carcinoma, and more.

Pages

Bloomberg reports AstraZeneca may conduct another study of its candidate SARS-CoV-2 vaccine after dosing error.

Moderna is applying for an Emergency Use Authorization for its coronavirus vaccine, according to the New York Times.

The National Health Service is to conduct a trial of Grail's blood-based screening test for cancer.

In PLOS this week: somatic mutation patterns of glioblastomas among Lebanese patients, phenome-wide study using UK Biobank data, and more.